Publication | Open Access

Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier: ChiCTR1800016615)

OphthalmologyMedicineEgfr-mutant Nsclc—a ProspectiveIntrathecal Pemetrexed CombinedClinical TrialsPharmacotherapyCancer TreatmentOncologyRadiation OncologySingle-arm Phase 1/2Novel TherapyHealth Sciences